Phase IIIb Study of Out of Specification Tisagenlecleucel

Conditions:   B-cell Acute Lymphoblastic Leukemia;   Diffuse Large B-cell Lymphoma Intervention:   Biological: Tisagenlecleucel Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - September 18, 2019 Category: Research Source Type: clinical trials